Microbix Biosystems Inc. (TSE:MBX – Get Free Report)’s stock price reached a new 52-week high on Wednesday . The stock traded as high as C$0.50 and last traded at C$0.50, with a volume of 1457199 shares trading hands. The stock had previously closed at C$0.44.
Microbix Biosystems Trading Up 19.5 %
The business’s 50-day simple moving average is C$0.37 and its 200-day simple moving average is C$0.35. The company has a market cap of C$71.08 million, a price-to-earnings ratio of 13.00 and a beta of 0.34. The company has a debt-to-equity ratio of 22.68, a current ratio of 6.62 and a quick ratio of 5.57.
About Microbix Biosystems
Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.
Read More
- Five stocks we like better than Microbix Biosystems
- Stock Splits, Do They Really Impact Investors?
- Oracle Announces Game-Changing News for the AI Industry
- What is MarketRank™? How to Use it
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Health Care Stocks Explained: Why You Might Want to Invest
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
